Literature DB >> 27671718

Validation in Support of Internationally Harmonised OECD Test Guidelines for Assessing the Safety of Chemicals.

Anne Gourmelon1, Nathalie Delrue2.   

Abstract

Ten years elapsed since the OECD published the Guidance document on the validation and international regulatory acceptance of test methods for hazard assessment. Much experience has been gained since then in validation centres, in countries and at the OECD on a variety of test methods that were subjected to validation studies. This chapter reviews validation principles and highlights common features that appear to be important for further regulatory acceptance across studies. Existing OECD-agreed validation principles will most likely generally remain relevant and applicable to address challenges associated with the validation of future test methods. Some adaptations may be needed to take into account the level of technique introduced in test systems, but demonstration of relevance and reliability will continue to play a central role as pre-requisite for the regulatory acceptance. Demonstration of relevance will become more challenging for test methods that form part of a set of predictive tools and methods, and that do not stand alone. OECD is keen on ensuring that while these concepts evolve, countries can continue to rely on valid methods and harmonised approaches for an efficient testing and assessment of chemicals.

Keywords:  Integrated approaches; Mutual acceptance; OECD validation principles; Test Guidelines

Mesh:

Year:  2016        PMID: 27671718     DOI: 10.1007/978-3-319-33826-2_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  7 in total

1.  Folic acid-nanoscale gadolinium-porphyrin metal-organic frameworks: fluorescence and magnetic resonance dual-modality imaging and photodynamic therapy in hepatocellular carcinoma.

Authors:  Yang Chen; Wei Liu; Yue Shang; Peipei Cao; Jianlin Cui; Zongjin Li; Xuebo Yin; Yuhao Li
Journal:  Int J Nanomedicine       Date:  2018-12-19

2.  Hypoxia-Activated Prodrug Derivatives of Carbonic Anhydrase Inhibitors in Benzenesulfonamide Series: Synthesis and Biological Evaluation.

Authors:  Emilie Anduran; Ashok Aspatwar; Nanda-Kumar Parvathaneni; Dennis Suylen; Silvia Bua; Alessio Nocentini; Seppo Parkkila; Claudiu T Supuran; Ludwig Dubois; Philippe Lambin; Jean-Yves Winum
Journal:  Molecules       Date:  2020-05-18       Impact factor: 4.411

3.  Design, synthesis, in vitro inhibition and toxicological evaluation of human carbonic anhydrases I, II and IX inhibitors in 5-nitroimidazole series.

Authors:  Ashok Aspatwar; Nanda Kumar Parvathaneni; Harlan Barker; Emilie Anduran; Claudiu T Supuran; Ludwig Dubois; Philippe Lambin; Seppo Parkkila; Jean-Yves Winum
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

4.  Toxicity evaluation of sulfamides and coumarins that efficiently inhibit human carbonic anhydrases.

Authors:  Ashok Aspatwar; Emanuela Berrino; Silvia Bua; Fabrizio Carta; Clemente Capasso; Seppo Parkkila; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

5.  Use of Zebrafish Embryo Assay to Evaluate Toxicity and Safety of Bioreactor-Grown Exopolysaccharides and Endopolysaccharides from European Ganoderma applanatum Mycelium for Future Aquaculture Applications.

Authors:  Wan Abd Al Qadr Imad Wan-Mohtar; Zul Ilham; Adi Ainurzaman Jamaludin; Neil Rowan
Journal:  Int J Mol Sci       Date:  2021-02-07       Impact factor: 5.923

6.  Scientific Validation of Human Neurosphere Assays for Developmental Neurotoxicity Evaluation.

Authors:  Katharina Koch; Kristina Bartmann; Julia Hartmann; Julia Kapr; Jördis Klose; Eliška Kuchovská; Melanie Pahl; Kevin Schlüppmann; Etta Zühr; Ellen Fritsche
Journal:  Front Toxicol       Date:  2022-03-02

7.  In vitro inhibition of Mycobacterium tuberculosis β-carbonic anhydrase 3 with Mono- and dithiocarbamates and evaluation of their toxicity using zebrafish developing embryos.

Authors:  Ashok Aspatwar; Milka Hammaren; Mataleena Parikka; Seppo Parkkila; Fabrizio Carta; Murat Bozdag; Daniela Vullo; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.